Apolipoprotein e deficiency leads to altered brain uptake of alpha tocopherol injected into lateral cerebral ventricles

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 7, 2007, Pages 797-803

  Vatassery, Govind T ^a,b   Quach, Hung T ^a   Smith, W Ed ^a   SantaCruz, Karen S ^b   Roy, Sabita ^b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apolipoprotein E; Cerebral ventricles; Cholesterol; Deficiency; Uptake; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN VENTRICLE; CEREBELLUM; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG UPTAKE; HIPPOCAMPUS; HYPERLIPOPROTEINEMIA TYPE 3; HYPOTHALAMUS; ISOTOPE LABELING; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PONS; PRIORITY JOURNAL;

ALPHA-TOCOPHEROL; ANIMALS; APOLIPOPROTEINS E; BRAIN; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

ANIMALIA; MUS;

EID: 34250005123     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.04.006     Document Type: Article

References (20)

1. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
2. Farrer L.A., Cupples A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and Van Duijn C.M. ApoE and Alzheimer's disease meta analysis consortium, effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. J. Am. Med. Assoc. 278 (1997) 1349-1356
3. Mahley R.W., Weisgraber K.H., and Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5644-5651
4. Pratico D., Rokach J., and Tangirala R.K. Brains of aged apolipoprotein E-deficient mice have increased levels of F2-isoprostanes, in vivo markers of lipid peroxidation. J. Neurochem. 73 (1999) 736-741
5. Shea T.B., Rogers E., Ashline D., Ortiz D., and Sheu M.S. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic. Biol. Med. 33 (2002) 1115-1120
6. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growden J., Cotman C.W., Pfeiffer E., Schneider L.S., and Thal L.J. A controlled trial of seligiline, alpha tocopherol, or both as treatment for Alzheimer's disease. New Engl. J. Med. 336 (1997) 1216-1222
7. Vatassery G.T., Lam C., Smith W.E., and Quach H.T. Apolipoprotein E exerts selective and differential control over vitamin E concentrations in different areas of mammalian brain. J. Neurosci. Res. 84 (2006) 1335-1342
8. Franklin K.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, New York
9. Glowinski J., and Iversen L.L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13 (1966) 655-669
10. Vatassery G.T., Smith W.E., and Quach H.T. A liquid chromatographic method for the simultaneous determination of alpha tocopherol and tocopherolquinone in human red blood cells and other biological samples where tocopherol is easily oxidized during sample treatment. Anal. Biochem. 214 (1993) 426-430
11. Markwell M.A.K., Haas S.M., Bieber L.L., and Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87 (1978) 206-210
12. Gallo-Torres H.E. In: Machlin L.J. (Ed). Vitamin E - A comprehensive Treatise (1980), Marcel Dekker Inc., New York 193-267
13. Johanson C.E., Duncan J.A., Stopa E.G., and Baird A. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm. Res. 22 (2005) 1011-1037
14. Abbott N.J. Evidence for bulk flow of brain interstitial fluid: significance in physiology and pathology. Neurochem. Int. 45 (2004) 545-552
15. Greitz D., and Hannerz J. A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography. Am. J. Neuroradiol. 17 (1996) 431-438
16. Roheim P.S., Carey M., Forte T., and Vega G.L. Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 4646-4649
17. Pardridge W.M. Transport of nutrients and hormones through the blood-brain barrier. Fed. Proc. 43 (1984) 201-204
18. LaDu M.J., Gilligan S.M., Lukens J.R., Cabana V.G., Reardon C.A., Van Eldik L.J., and Holtzman D.M. Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70 (1998) 2070-2081
19. Mardones P., Strobel P., Miranda S., Leighton F., Quinones V., Amigo L., Rosowski J., Krieger M., and Rigotti A. Alpha tocopherol metabolism is abnormal in scavenger receptor class B type I (SR-B1)-deficient mice. J. Nutr. 132 (2002) 443-449
20. Burton G.W., Wronska U., Stone L., Foster D.O., and Ingold K.U. Biokinetics of dietary RRR-alpha tocopherol in the male guinea pig at three dietary levels of vitamin C and two levels of vitamin E, evidence that vitamin C does not spare vitamin E in vivo. Lipids 25 (1990) 199-210